| 2024/04/16 15:28:00 | |
|---|---|
| Price | |
| 214.30 SEK | |
| Difference | 0.00% (0.00) |
General attributes
| ISIN | SE0000202624 |
| Symbol | GETI B |
| Exchange | Nasdaq Stockholm |
| Currency | SEK |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 4,708 EUR |
| Benchmark | OMX STOCKHOLM 30 INDEX |
Market data
| Bid (Bid size) | 214.20 SEK (1,704) |
| Ask (Ask size) | 214.40 SEK (1,009) |
| Open | 211.90 SEK |
| High | 216.60 SEK |
| Low | 211.10 SEK |
| Close (prev. day) | 214.30 SEK |
| VWAP | 214.926099 SEK |
| Volume (pcs) | 369,026 |
| Trading volume | 79,345,616.25 |
| Number of trades | 1,583 |
| Last size | 248 |
Futures and Options
| Related Futures | 41 |
| Related Options | - |
PDF Downloads
| Company report: GETINGE AB SER. B |  |
Add Benchmark:
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/16 15:28:00 | |
|---|---|
| Price | |
| 214.30 SEK | |
| Difference | 0.00% (0.00) |
General attributes
| ISIN | SE0000202624 |
| Symbol | GETI B |
| Exchange | Nasdaq Stockholm |
| Currency | SEK |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 4,708 EUR |
| Benchmark | OMX STOCKHOLM 30 INDEX |
Market data
| Bid (Bid size) | 214.20 SEK (1,704) |
| Ask (Ask size) | 214.40 SEK (1,009) |
| Open | 211.90 SEK |
| High | 216.60 SEK |
| Low | 211.10 SEK |
| Close (prev. day) | 214.30 SEK |
| VWAP | 214.926099 SEK |
| Volume (pcs) | 369,026 |
| Trading volume | 79,345,616.25 |
| Number of trades | 1,583 |
| Last size | 248 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +5.31% | -17.07% | -19.22% |
| Perf (abs.) | +10.80 | -44.10 | -51.00 |
| Beta | 0.97 | 1.23 | 0.94 |
| Volatility | 31.66 | 34.25 | 36.70 |
Add Benchmark:
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 213.22 SEK (754,887) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 210.17 SEK (768,656) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 215.42 SEK (774,420) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 212.29 SEK (800,357) |
| YTD High | date | 233.80 SEK (2024/01/03) |
| YTD Low | date | 193.05 SEK (2024/02/01) |
| 52 Weeks High | date | 275.20 SEK (2023/04/26) |
| 52 Weeks Low | date | 174.20 SEK (2023/07/07) |
All listings for GETINGE AB SER. B
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| BX Swiss | 2024/02/27 | 18:00 | 17.801 CHF | 0.01 | 1 |
| Berlin | 2024/04/16 | 08:05 | 18.17 EUR | 0.00 | 1 |
| Duesseldorf | 2024/04/16 | 12:31 | 18.375 EUR | 0.00 | 3 |
| FINRA other OTC Issues | 2024/04/15 | 17:56 | 19.706 USD | 0.00 | 1 |
| Frankfurt | 2024/04/16 | 08:02 | 18.175 EUR | 0.00 | 1 |
| Hanover | 2024/04/16 | 08:00 | 18.275 EUR | 0.00 | 1 |
| London Stock Exchange European Trade Reporting | 2024/04/16 | 09:00 | 211.95 SEK | 0.00 | 1 |
| Munich | 2024/04/16 | 08:05 | 18.305 EUR | 0.00 | 1 |
| Nasdaq Stockholm | 2024/04/16 | 15:28 | 214.30 SEK | 79.35 | 1,583 |
| Stuttgart | 2024/04/16 | 10:31 | 18.57 EUR | 0.00 | 2 |
| Tradegate | 2024/04/16 | 08:02 | 18.26 EUR | 0.00 | 2 |
Company Logo
Contact Details
| GETINGE AB |
| - - |
| Lindholmspiren 7A - 417 56 Gothenburg |
| Telefon: +46-10-335-0000 |
| Fax: +46-10-335-5640 |
| E-mail: info@getinge.com |
PDF Downloads
| Company report: GETINGE AB SER. B | |
Company Profile
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It offers products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. The firm operates through the following segments: Acute Care Therapies, Life Science and Surgical Workflows. The Acute Care Therapies segment offers solutions for life support in acute health conditions. The Life Science segment offers a comprehensive range of equipment, technical expertise and consultation to prevent contamination in biopharmaceutical production, biomedical research, medical device manufacturing and laboratory applications. The Surgical Workflows segment offers products and services for efficient disinfection and sterilization of instruments used in operations, operating tables and other high-quality hardware for operating rooms and advanced IT systems for efficient and secure hospital workflows. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden. |
Members of Management Board
| Mattias Perjos | Chairman of Managing Board |
| Anna Romberg | Member of Executive Committee |
| Carsten Blecker | Member of Executive Committee |
| Harald Castler | Member of Executive Committee |
| Jeanette Hedén Carlsson | Member of Executive Committee |
| Jens Viebke | Member of Executive Committee |
| Lars Sandström | Member of Executive Committee |
| Lena Hagman | Member of Executive Committee |
| Magnus Lundbäck | Member of Executive Committee |
| Stéphane Le Roy | Member of Executive Committee |
Board of directors
| Johan Malmquist | Chairman of Supervisory Board |
| Barbro Fridén | Member of Supervisory Board |
| Carl Reinhold Adolf Bennet | Member of Supervisory Board |
| Kristian Samuelsson | Member of Supervisory Board |
| Cecilia Margaretha Daun-Wennborg | Member of Supervisory Board |
| Dan Frohm | Member of Supervisory Board |
| Eva Christina Malin Persson | Member of Supervisory Board |
| Fredrik Brattborn | Member of Supervisory Board |
| Frida Gustafsson | Member of Supervisory Board |
| Johan Bygge | Member of Supervisory Board |
| Pontus Kallén | Member of Supervisory Board |
| Åke Larsson | Member of Supervisory Board |